Home » Nichi-Iko Picks Up Sagent Pharmaceuticals
Nichi-Iko Picks Up Sagent Pharmaceuticals
Nichi-Iko Pharmaceutical has entered into an agreement to acquire Sagent Pharmaceuticals for nearly $736 million.
The acquisition combines Nichi-Iko’s biosimilar portfolio and Sagent’s line of injectables.
Currently, no operational changes are expected for Sagent Pharmaceuticals. — Anisa Jibrell
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May